Print
26 March 2014
Marchmont Innovation News
Scientists in Novosibirsk are seeking a Russian Scientific Fund grant in an effort to create a cell bank—a key to faster identification of most working therapies for a variety of human diseases, Nanonewsnet.ru reported , citing Academician Valentin Vlasov, the director of the local Institute of Chemical Biology and Fundamental Medicine.
According to the scientist, the future bank will store cells taken primarily from people suffering from central nervous system disorders, including Alzheimer’s and Parkinson patients.
Researchers will use the cells to develop what he said would be models simulating the clinical course of such diseases, and to come up with appropriate solutions to successfully treat the disorders.
Acad. Vlasov further said the project will be joined by a number of other research entities, such as the Meshalkin Novosibirsk Research Institute of Circulatory Pathologies. He stopped short of specifying any timeframe for the biobank project, though.
“We will see later this year whether we win a tender or we don’t,” Mr. Vlasov concluded.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.